Area of research
Molecular Biology · Immunology
Research interest
Research interests include Single-cell and spatial transcriptomics, T-cell and B-cell Immunology, Epigenetics and DNA Methylation, and Chromatin Remodeling and Cancer.
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
An optimized workflow for single-cell transcriptomics and repertoire profiling of purified lymphocytes from clinical samples
Interplay between the human gut microbiome and host metabolism
The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa
Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
Time Series Integrative Analysis of RNA Sequencing and MicroRNA Expression Data Reveals Key Biologic Wound Healing Pathways in Keloid-Prone Individuals
De novo mutations implicate novel genes in systemic lupus erythematosus
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment
Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome
Cluster stability in the analysis of mass cytometry data
Phenotypic Complexity of the Human Regulatory T Cell Compartment Revealed by Mass Cytometry
Retinoic Acid Is Essential for Th1 Cell Lineage Stability and Prevents Transition to a Th17 Cell Program
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility
IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers
Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control